Touch the screen or click to continue...
Checking your browser...
gnurose.pages.dev

Henri termeer biography

          Henri termeer net worth.

          Henri termeer cause of death

        1. Henri termeer cause of death
        2. Henri Termeer was one of the first of a pioneering group of business executives who built a disparate group of fledgling companies into a biotech industry.
        3. Henri termeer net worth
        4. Henri Termeer was a pioneer of the biotechnology industry, combining an astute business mind with a deep passion and empathy for patients and their families.
        5. Henri Termeer was a non-medically qualified pioneer in the biotech industry, and in the development, production and sale of orphan drugs.

          6. Henri Termeer

          American businessman (–)

          Henri A. Termeer (February 28, – May 12, )[5] was a Dutch biotechnology executive and entrepreneur who is considered a pioneer[6] in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme.[7] Termeer created a business model[6] adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders[6] known as orphan diseases that mainly affect children.

          Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers.

          As CEO of Genzyme from to , he developed corporate strategies for growth including optimizing institutional embeddedness[8] nurturing vast net